First American Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Hold
21,347
0.07% 132
2026
Q1
$1.29M Buy
21,347
+1,352
+7% +$78.8K 0.08% 124
2025
Q4
$1.08M Buy
19,995
+44
+0.2% +$2.12K 0.07% 134
2025
Q3
$900K Hold
19,951
0.06% 137
2025
Q2
$924K Hold
19,951
0.06% 129
2025
Q1
$1.22M Hold
19,951
0.09% 119
2024
Q4
$1.13M Sell
19,951
-12
-0.1% -$670 0.08% 121
2024
Q3
$1.03M Sell
19,963
-530
-3% -$24.9K 0.07% 123
2024
Q2
$851K Buy
20,493
+422
+2% +$18.9K 0.06% 124
2024
Q1
$1.09M Sell
20,071
-175
-0.9% -$8.91K 0.08% 122
2023
Q4
$1.04M Sell
20,246
-4,128
-17% -$217K 0.09% 119
2023
Q3
$1.41M Sell
24,374
-1,028
-4% -$63K 0.13% 108
2023
Q2
$1.62M Sell
25,402
-11,296
-31% -$757K 0.14% 103
2023
Q1
$2.54M Sell
36,698
-25,906
-41% -$1.83M 0.23% 89
2022
Q4
$4.5M Sell
62,604
-1,584
-2% -$119K 0.43% 59
2022
Q3
$4.56M Buy
64,188
+1,882
+3% +$137K 0.48% 57
2022
Q2
$4.8M Buy
62,306
+2,951
+5% +$225K 0.49% 56
2022
Q1
$4.33M Buy
59,355
+9,561
+19% +$642K 0.37% 65
2021
Q4
$3.1M Sell
49,794
-9,122
-15% -$535K 0.16% 123
2021
Q3
$3.49M Buy
58,916
+44
+0.1% +$2.9K 0.2% 106
2021
Q2
$3.93M Sell
58,872
-1,562
-3% -$102K 0.23% 95
2021
Q1
$3.81M Sell
60,434
-8,776
-13% -$546K 0.24% 94
2020
Q4
$4.29M Buy
69,210
+7,064
+11% +$434K 0.29% 82
2020
Q3
$3.75M Sell
62,146
-291
-0.5% -$17.5K 0.22% 110
2020
Q2
$3.67M Buy
62,437
+34,652
+125% +$2.07M 0.23% 111
2020
Q1
$1.55M Buy
27,785
+1,085
+4% +$66.3K 0.12% 165
2019
Q4
$1.71M Buy
+26,700
New +$1.53M 0.11% 178
2019
Q2
$1.14M Hold
25,027
0.08% 195
2019
Q1
$1.19M Sell
25,027
-189
-0.7% -$9.41K 0.09% 183
2018
Q4
$1.31M Sell
25,216
-1,007
-4% -$54.1K 0.1% 166
2018
Q3
$1.63M Buy
+26,223
New +$1.56M 0.11% 167
2018
Q1
$1.65M Sell
26,095
-47
-0.2% -$3.02K 0.12% 156
2017
Q4
$1.6M Sell
26,142
-335
-1% -$21K 0.12% 158
2017
Q3
$1.69M Sell
26,477
-202
-0.8% -$11.8K 0.13% 169
2017
Q2
$1.49M Sell
26,679
-2,043
-7% -$111K 0.12% 168
2017
Q1
$1.56M Sell
28,722
-1,150
-4% -$63.1K 0.13% 162
2016
Q4
$1.75M Sell
29,872
-51,662
-63% -$2.82M 0.15% 153
2016
Q3
$4.4M Sell
81,534
-11,204
-12% -$720K 0.4% 61
2016
Q2
$6.82M Sell
92,738
-779
-0.8% -$55K 0.66% 37
2016
Q1
$5.97M Buy
93,517
+66,337
+244% +$4.18M 0.59% 37
2015
Q4
$1.87M Buy
27,180
+668
+3% +$44.1K 0.19% 84
2015
Q3
$1.57M Hold
26,512
0.17% 82
2015
Q2
$1.76M Hold
26,512
0.17% 88
2015
Q1
$1.71M Hold
26,512
0.17% 90
2014
Q4
$1.56M Hold
26,512
0.17% 88
2014
Q3
$1.36M Sell
26,512
-75
-0.3% -$3.75K 0.15% 86
2014
Q2
$1.29M Hold
26,587
0.14% 89
2014
Q1
$1.38M Hold
26,587
0.15% 90
2013
Q4
$1.41M Buy
26,587
+55
+0.2% +$2.8K 0.16% 90
2013
Q3
$1.23M Sell
26,532
-55,437
-68% -$2.43M 0.15% 89
2013
Q2
$3.66M Buy
+81,969
New +$3.56M 0.51% 53

Other funds holding BMY

First American Bank's BMY Position: Q2 2026 in Review

First American Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 21,347 shares worth $1.23M. The position accounts for 0.07% of the portfolio, ranked #132.

First American Bank first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.82M in Q2 2016. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First American Bank held 21,347 shares of Bristol-Myers Squibb worth $1.23M as of Q2 2026.
  • First American Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.07% of First American Bank's portfolio in Q2 2026, its #132 holding.
  • First American Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • First American Bank's Bristol-Myers Squibb position peaked at $6.82M in Q2 2016.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.